These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 789263)
1. Macrophage function in leprosy. Parmaswaran M; Girdhar BK; Deo MG; Kandhari KC; Bhutani LK Int J Lepr Other Mycobact Dis; 1976; 44(3):340-5. PubMed ID: 789263 [TBL] [Abstract][Full Text] [Related]
2. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction. Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031 [TBL] [Abstract][Full Text] [Related]
3. Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy. Godal T; Rees RJ Int J Lepr Other Mycobact Dis; 1970; 38(4):439-42. PubMed ID: 4929374 [No Abstract] [Full Text] [Related]
4. The immunobiology of leprosy. Kaplan G; Cohn ZA Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911 [TBL] [Abstract][Full Text] [Related]
5. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF. Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941 [TBL] [Abstract][Full Text] [Related]
6. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients. Robinson P; Mahadevan PR J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228 [TBL] [Abstract][Full Text] [Related]
7. Hydrolytic enzymes in macrophages from leprosy patients in presence of Mycobacterium leprae. Marolia J; Mahadevan PR Indian J Lepr; 1984; 56(4):776-83. PubMed ID: 6398340 [TBL] [Abstract][Full Text] [Related]
9. Biochemical alteration in cells following phagocytosis of M. leprae--the consequence--a basic concept. Mahadevan PR; Antia NH Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):167-71. PubMed ID: 6995358 [TBL] [Abstract][Full Text] [Related]
10. Radiolabelled M. leprae resident in human macrophage cultures as an in vitro indicator of effective immunity in human leprosy. Prasad HK; Singh R; Nath I Clin Exp Immunol; 1982 Sep; 49(3):517-22. PubMed ID: 6756718 [TBL] [Abstract][Full Text] [Related]
11. The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum. Krahenbuhl JL; Welch TM; Levy L Int J Lepr Other Mycobact Dis; 1976; 44(1-2):206-15. PubMed ID: 776858 [TBL] [Abstract][Full Text] [Related]
12. Macrophage membrane alterations in leprosy as determined by change in sialic acid level. Agarwal S; Vemuri N; Mahadevan PR J Clin Lab Immunol; 1986 Mar; 19(3):119-22. PubMed ID: 3519974 [TBL] [Abstract][Full Text] [Related]
13. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Nath I; Van Rood JJ; Mehra NK; Vaidya MC Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335 [TBL] [Abstract][Full Text] [Related]
14. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma. Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450 [TBL] [Abstract][Full Text] [Related]
15. Antigenic protein from Mycobacterium leprae released in macrophages in vitro as indicator of viability of bacteria. Nair I; Mahadevan PR Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):540-7. PubMed ID: 2205688 [TBL] [Abstract][Full Text] [Related]
16. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278 [TBL] [Abstract][Full Text] [Related]
17. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780 [TBL] [Abstract][Full Text] [Related]
18. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193 [TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. Kaplan G; Nathan CF; Gandhi R; Horwitz MA; Levis WR; Cohn ZA J Immunol; 1986 Aug; 137(3):983-7. PubMed ID: 3088117 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies. Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]